Drug Shortage Report for IMOVANE

Last updated on 2019-03-08 History
Report ID 45394
Drug Identification Number 02216167
Brand name IMOVANE
Common or Proper name IMOVANE 5MG TB BTX100
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ZOPICLONE
Strength(s) 5.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N05CF
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-04-27
Actual start date 2018-04-27
Estimated end date 2019-03-08
Actual end date 2019-03-07
Shortage status Resolved
Updated date 2019-03-08
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2019-02-15 French Compare
v22 2019-02-18 English Compare
v23 2019-02-18 French Compare
v24 2019-02-18 English Compare
v25 2019-02-18 French Compare
v26 2019-02-26 English Compare
v27 2019-02-26 French Compare
v28 2019-03-08 English Compare
v29 2019-03-08 French Compare

Showing 21 to 29 of 29